These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 18495806

  • 1. Valproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled study.
    Aliyev ZN, Aliyev NA.
    Alcohol Alcohol; 2008; 43(4):456-9. PubMed ID: 18495806
    [Abstract] [Full Text] [Related]

  • 2. Application of glycine in acute alcohol hallucinosis.
    Aliyev NA, Aliyev ZN.
    Hum Psychopharmacol; 2005 Dec; 20(8):591-4. PubMed ID: 16247737
    [Abstract] [Full Text] [Related]

  • 3. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial.
    Mitsikostas DD, Polychronidis I.
    Funct Neurol; 1997 Dec; 12(5):267-76. PubMed ID: 9439944
    [Abstract] [Full Text] [Related]

  • 4. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
    Nakamura M, Ogasa M, Guarino J, Phillips D, Severs J, Cucchiaro J, Loebel A.
    J Clin Psychiatry; 2009 Jun; 70(6):829-36. PubMed ID: 19497249
    [Abstract] [Full Text] [Related]

  • 5. Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: randomized, double-blind placebo-controlled study.
    Aliyev NA, Aliyev ZN.
    Eur Psychiatry; 2008 Mar; 23(2):109-14. PubMed ID: 17945470
    [Abstract] [Full Text] [Related]

  • 6. A comparison of anticonvulsants in the treatment of impulsive aggression.
    Stanford MS, Helfritz LE, Conklin SM, Villemarette-Pittman NR, Greve KW, Adams D, Houston RJ.
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):72-7. PubMed ID: 15727506
    [Abstract] [Full Text] [Related]

  • 7. The use of sodium valproate in the treatment of alcoholism.
    Minuk GY, Rockman GE, German GB, Duerksen DR, Borrett G, Hoeschen L.
    J Addict Dis; 1995 Feb; 14(2):67-74. PubMed ID: 8541361
    [Abstract] [Full Text] [Related]

  • 8. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 10. [Alcoholic hallucinosis: response to treatment].
    Vicente Muelas N, Ríos Rial B, Ochoa Mangado E.
    Arch Neurobiol (Madr); 1990 Jun; 53(5):192-5. PubMed ID: 2091563
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
    Waberzinek G, Marková J, Mastík J.
    Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725
    [Abstract] [Full Text] [Related]

  • 12. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial.
    Brodie MJ, Rosenfeld WE, Vazquez B, Sachdeo R, Perdomo C, Mann A, Arroyo S.
    Epilepsia; 2009 Aug; 50(8):1899-909. PubMed ID: 19490053
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Scherl EJ, Pruitt R, Gordon GL, Lamet M, Shaw A, Huang S, Mareya S, Forbes WP.
    Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Aurora SK, Rozen TD, Kori SH, Shrewsbury SB.
    Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
    [Abstract] [Full Text] [Related]

  • 16. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J, N01103 Levetiracetam Study Group.
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [Abstract] [Full Text] [Related]

  • 17. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V.
    Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
    [Abstract] [Full Text] [Related]

  • 18. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M.
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders.
    Hellings JA, Weckbaugh M, Nickel EJ, Cain SE, Zarcone JR, Reese RM, Hall S, Ermer DJ, Tsai LY, Schroeder SR, Cook EH.
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):682-92. PubMed ID: 16190799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.